J&J 自己还揩自己的油

https://www.reuters.com/legal/litigation/jj-faces-class-action-over-employees-prescription-drug-costs-2024-02-05/

The lawsuit, opens new tab, filed in New Jersey federal court by Ann Lewandowski, a healthcare policy and advocacy director, accuses Johnson & Johnson of breaching its duty under the federal Employee Retirement Income Security Act of 1974 (ERISA) to prudently manage employee benefit plans.

The plans, for example, pay $1,629 for a 90-pill prescription of HIV antiviral drug abacavir-lamivudine that costs pharmacies about $180, according to the complaint. And while prescriptions of teriflunomide, used to treat multiple sclerosis, typically cost no more than $77 out of pocket, Johnson & Johnson's health plans pay $10,200, the lawsuit claims.